
Thrombolex
Thrombolex innovates efficient endovascular catheters for precise, cost-effective treatment of A+VTE conditions since 2016.
- 11
- Company
- Kingston, NJ, USUnited States
Founded in 2016, Thrombolex designs, develops, manufactures, and distributes innovative endovascular catheters aimed at treating arterial and venous thromboembolic (A+VTE) conditions. The company's mission is to enhance patient care by creating catheters that allow for the precise infusion of physician-specified fluids, including thrombolytics, into targeted areas of the peripheral vasculature. This approach aims to treat thrombus more efficiently, in less time, and with lower doses. Their product line includes the BASHIR™ Endovascular Catheter series.
Thrombolex has garnered attention for its sophisticated catheter technology, which offers ease of placement and shorter procedure times. Notable affiliated individuals include experienced medical professionals and industry experts who contribute to the company’s innovative edge. The company has achieved significant milestones in clinical efficacy and safety, making a notable impact on the treatment of thromboembolic conditions. Their advancements have positioned them as a key player in the endovascular device market.
Similar Companies
Advanced Catheter Therapies
acatheter.com

NeuRx Medical
neurxmed.com

Endovascular Engineering

Embolx
embolx.com

SonoVascular
sonovascular.com

Flow Medical
flowmedical.co

Akura Medical
akuramedical.com
Endovention

Q'Apel Medical
qapelmedical.com
Control Medical Technology

eLum Technologies
Venarum Medical

Bi02 Medical
bio2medical.com

Traverse Vascular

Bluegrass Vascular Technologies

Thrombolytic Science
tsillc.net

FastWave Medical

Access Vascular

Osciflex
osciflex.com
Alucent Biomedical
alucentmedical.com
Quick Facts
Who are Thrombolex's competitors?
Companies similar to Thrombolex include Advanced Catheter Therapies, NeuRx Medical, Endovascular Engineering and Embolx.
When was Thrombolex founded?
Thrombolex was founded in 2016.
Where is Thrombolex's headquarters located?
Thrombolex's headquarters is located in Kingston, NJ, US.
How much disclosed funding has Thrombolex raised?
As of Mar 16, 2026, Thrombolex has disclosed funding of $16.8M (USD). Undisclosed round amounts are excluded.
How many employees does Thrombolex have?
Thrombolex has 11 employees as of Feb 5, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Model
- Revenue
- Customer
- Main Product
- Also Known As
- Thrombolex, Inc.
- Thrombolex, LLC
- Headquarters
- 4416 Route 27
- Suite A
- Kingston, NJ, 08528
- US
- SEC CIK
- 0001703764
- EIN
- 81-2837910
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- SIC
- 5000Wholesale Trade-durable Goods
- 5040Professional And Commercial Equipment And Supplies
- 5047Medical, Dental, And Hospital Equipment And Supplies
- Industry
- —Health Care Companies
- —Manufacturing Companies
- —Medical Organizations
- —Medical Technology Companies
Show 7 more industry codes
- NAICS
- 330000Manufacturing
- 620000Health Care and Social Assistance
- 623000Nursing and Residential Care Facilities
- SIC
- 3900Miscellaneous Manufacturing Industries
- 8000Health Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified